Latest Financial Results
Q2 2021
Quarter Ended Jun 30, 2021
$351.7M
Total revenue of $351.7 million, up 6% from $330.3 million for the prior-year period.
$74.0M
Net income of $74.0 million, compared to $84.0 million for the prior-year period.
$25.8M
Net income attributable to ApolloMed increased to $25.8 million, from $11.1 million for the prior-year period.
For complete information regarding our financials, see our periodic filings